Literature DB >> 2010091

Analysis of the DNA-binding and activation properties of the human transcription factor AP-2.

T Williams1, R Tjian.   

Abstract

The mammalian transcription factor AP-2 is a sequence-specific DNA-binding protein expressed in neural crest lineages and regulated by retinoic acid. Here we report a structure/function analysis of the DNA-binding and transcription activation properties of the AP-2 protein. DNA contact studies indicate that AP-2 binds as a dimer to a palindromic recognition sequence. Furthermore, cross-linking and immunoprecipitation data illustrate that AP-2 exists as a dimer even in the absence of DNA. Examination of cDNA mutants reveals that the sequences responsible for DNA binding are located in the carboxy-terminal half of the protein. In addition, a domain mediating dimerization forms an integral component of this DNA-binding structure. Expression of AP-2 in mammalian cells demonstrates that transcriptional activation requires an additional amino-terminal domain that contains an unusually high concentration of proline residues. This proline-rich activation domain also functions when attached to the heterologous DNA-binding region of the GAL4 protein. This study reveals that although AP-2 shares an underlying modular organization with other transcription factors, the regions of AP-2 involved in transcriptional activation and DNA binding/dimerization have novel sequence characteristics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010091     DOI: 10.1101/gad.5.4.670

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  147 in total

1.  The myogenic regulatory circuit that controls cardiac/slow twitch troponin C gene transcription in skeletal muscle involves E-box, MEF-2, and MEF-3 motifs.

Authors:  T H Christensen; L Kedes
Journal:  Gene Expr       Date:  1999

2.  Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta.

Authors:  M Moser; A Pscherer; C Roth; J Becker; G Mücher; K Zerres; C Dixkens; J Weis; L Guay-Woodford; R Buettner; R Fässler
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

3.  A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator.

Authors:  R Yagi; L F Chen; K Shigesada; Y Murakami; Y Ito
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

4.  Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.

Authors:  O Nyormoi; Z Wang; D Doan; M Ruiz; D McConkey; M Bar-Eli
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  Identification of the promoter of the myelomonocytic leukocyte integrin CD11b.

Authors:  D D Hickstein; D M Baker; K A Gollahon; A L Back
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

6.  Three novel MYB proteins with one DNA binding repeat mediate sugar and hormone regulation of alpha-amylase gene expression.

Authors:  Chung-An Lu; Tuan-hua David Ho; Shin-Lon Ho; Su-May Yu
Journal:  Plant Cell       Date:  2002-08       Impact factor: 11.277

7.  V-src-induced-transcription of the avian clusterin gene.

Authors:  Y Herault; G Chatelain; G Brun; D Michel
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

8.  Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).

Authors:  Jessica Finlay-Schultz; Andrew Canastar; Margaret Short; Mohamed El Gazzar; Christina Coughlan; Sherry Leonard
Journal:  J Biol Chem       Date:  2011-10-06       Impact factor: 5.157

9.  Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2.

Authors:  Valeria E Zarelli; Igor B Dawid
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

10.  Mechanism of cAMP regulation of renin gene transcription by proximal promoter.

Authors:  K Tamura; S Umemura; S Yamaguchi; T Iwamoto; S Kobayashi; A Fukamizu; K Murakami; M Ishii
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.